Jens Ahm Sørensen

Prof. Jens Ahm Sørensen

orcid

Research Focus & Metrics

Academic Career Length

39Years (1988-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2015 in European Journal of Cancer
Verified
Journal Article
Closed access
CSClare Schilling
Clare Schilling
SSSandro J. Stoeckli
Sandro J. Stoeckli
SHStephan K. Haerle
Stephan K. Haerle
MBMartina A. Broglie
Martina A. Broglie
GHGerhard F. Huber
Gerhard F. Huber
MMMark McGurk
Mark McGurk

24 April 2017 in Wound Repair and Regeneration
Verified
Journal Article
Closed access
PDF file
CKCarla R. Kruse
Carla R. Kruse
MSMansher Singh
Mansher Singh
STStefan Targosinski
Stefan Targosinski
ISIndranil Sinha
Indranil Sinha
JSJens Ahm Sørensen
Jens Ahm Sørensen
KNKristo Nuutila
Kristo Nuutila

15 June 2010 in Annals of Surgical Oncology
Verified
Journal Article
Closed access
PDF file
LALee W. T. Alkureishi
Lee W. T. Alkureishi
GRGary L. Ross
Gary L. Ross
TSTaimur Shoaib
Taimur Shoaib
DSDavid S. Soutar
David S. Soutar
ARA. Gerry Robertson
A. Gerry Robertson
FAFranco Alberti
Franco Alberti

13 December 2012 in Journal of Nuclear Medicine
Verified
Journal Article
Open access
PDF file
GAGunnar Antoni
Gunnar Antoni
MLMark Lubberink
Mark Lubberink
SESergio Estrada
Sergio Estrada
JAJan Axelsson
Jan Axelsson
KCKristina Carlson
Kristina Carlson
JSJens Ahm Sørensen
Jens Ahm Sørensen
Cardiac amyloidosis is a differential diagnosis in heart failure and is associated with high mortality. There is currently no noninvasive imaging test available for specific diagnosis. N-[methyl-11C]2-(4′-methylamino-phenyl)-6-hydroxybenzothiazole (11C-PIB) PET is used in the evaluation of brain amyloidosis. We evaluated the potential use of 11C-PIB PET in systemic amyloidosis affecting the heart. Methods: Patients (n = 10) diagnosed with systemic amyloidosis—including heart involvement of either monoclonal immunoglobulin light-chain (AL) or transthyretin (ATTR) type—and healthy volunteers (n = 5) were investigated with PET/CT using 11C-PIB to study cardiac amyloid deposits and with 11C-acetate to measure myocardial blood flow to study the impact of global and regional perfusion on PIB retention. Results: Myocardial 11C-PIB uptake was visually evident in all patients 15–25 min after injection and was not seen in any volunteer. A significant difference in 11C-PIB retention in the heart between patients and healthy controls was found. The data indicate that myocardial amyloid deposits in patients diagnosed with systemic amyloidosis could be visualized with 11C-PIB. No correlation between 11C-PIB retention index and myocardial blood flow as measured with 11C-acetate was found on the global level, whereas a positive correlation on the segmental level was seen in a single patient. Conclusion: 11C-PIB and PET could be a method to study systemic amyloidosis of type AL and ATTR affecting the heart and should be investigated further both as a diagnostic tool and as a noninvasive method for treatment follow-up.

16 March 2016 in British Journal of Surgery
Verified
Journal Article
Open access
PDF file
NHN. Hyldig
N. Hyldig
HBH. Birke‐Sorensen
H. Birke‐Sorensen
MKM. Kruse
M. Kruse
CVC. Vinter
C. Vinter
JJJ. S. Joergensen
J. S. Joergensen
CBC. Bille
C. Bille
Background: Postoperative wound complications are common following surgical procedures. Negative-pressure wound therapy (NPWT) is well recognized for the management of open wounds and has been applied recently to closed surgical incisions. The evidence base to support this intervention is limited. The aim of this study was to assess whether NPWT reduces postoperative wound complications when applied to closed surgical incisions. Methods: This was a systematic review and meta-analysis of randomized clinical trials of NPWT compared with standard postoperative dressings on closed surgical incisions. Results: Ten studies met the inclusion criteria, reporting on 1311 incisions in 1089 patients. NPWT was associated with a significant reduction in wound infection (relative risk (RR) 0·54, 95 per cent c.i. 0·33 to 0·89) and seroma formation (RR 0·48, 0·27 to 0·84) compared with standard care. The reduction in wound dehiscence was not significant. The numbers needed to treat were three (seroma), 17 (dehiscence) and 25 (infection). Methodological heterogeneity across studies led to downgrading of the quality of evidence to moderate for infection and seroma, and low for dehiscence. Conclusion: Compared with standard postoperative dressings, NPWT significantly reduced the rate of wound infection and seroma when applied to closed surgical wounds. Heterogeneity between the included studies means that no general recommendations can be made yet.

1 February 2020 in Journal of Plastic, Reconstructive & Aesthetic Surgery
Verified
Journal Article
Closed access
NTNavid Mohamadpour Toyserkani
Navid Mohamadpour Toyserkani
MJMads Gustaf Jørgensen
Mads Gustaf Jørgensen
STSiavosh Tabatabaeifar
Siavosh Tabatabaeifar
Tine Engberg DamsgaardTine Engberg Damsgaard
Tine Engberg Damsgaard
JSJens Ahm Sørensen
Jens Ahm Sørensen